Potassium Hydroxide → HCID 49846224, 화합물
반응식
[OH-].[K+].[C:3]([C:6]1[N:11]=[C:10]([C:12]2[CH:17]=[CH:16][C:15]([C:18]3[CH:23]=[CH:22][C:21]([CH2:24][C:25]([N:27]4[CH2:32][CH2:31][CH:30]([C:33]([O:35]CC)=[O:34])[CH2:29][CH2:28]4)=[O:26])=[CH:20][C:19]=3[Cl:38])=[CH:14][CH:13]=2)[C:9]([CH3:39])=[N:8][C:7]=1[CH3:40])(=[O:5])[NH2:4]>CC(O)(C)C>[C:3]([C:6]1[N:11]=[C:10]([C:12]2[CH:13]=[CH:14][C:15]([C:18]3[CH:23]=[CH:22][C:21]([CH2:24][C:25]([N:27]4[CH2:28][CH2:29][CH:30]([C:33]([OH:35])=[O:34])[CH2:31][CH2:32]4)=[O:26])=[CH:20][C:19]=3[Cl:38])=[CH:16][CH:17]=2)[C:9]([CH3:39])=[N:8][C:7]=1[CH3:40])(=[O:5])[NH2:4]참가 물질
4
반응 조건
- 온도
- 45 °C
실험 절차
Potassium hydroxide (91 mg, 1.63 mmol) was added in one portion to ethyl 1-(2-(4′-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)acetyl)piperidine-4-carboxylate (Intermediate 19-1; 290.7 mg, 0.54 mmol) in t-BuOH (3505 μL) at RT. The resulting solution was stirred at 45° C. for 5 hours a precipitate formed. The reaction mixture was quenched with 2M HCl (5 mL), The reaction mixture was evaporated to dryness and redissolved in water (10 mL), and filtered through nylon, washed with water and dried under vacuum. The crude product was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5μ silica, 50 mm diameter, 150 mm length), using decreasingly polar mixtures of water (containing 0.1% formic acid) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford 1-(2-(4′-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)-2-chlorobiphenyl-4-yl)acetyl)piperidine-4-carboxylic acid (59.8 mg, 21.71%) as a white solid.